Praxis Precisions Medicines Inc (PRAX)
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2025 Financial Results
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2025 Financial Results
Equillium - Equillium Announces Strategic Expansion of Cryptocurrency Treasury Reserve Strategy
Cognex Corporation - Cognex to Present at the KeyBanc Capital Markets Technology Leadership Forum
Star Equity Holdings to Release Second Quarter 2025 Financial Results on August 13
Lifeward Expands Distribution Partnership with SportsMed Ltd. to Add Coverage for United Arab Emirates and Entire Gulf Cooperation Council Region
Hyperfine Achieves Clinical Milestone Ahead of Plan With 100th Patient Enrolled in Neurology Office Study Using the Next-GenerationSwoop® System
New Form 8-K - Bioventus Inc. Filed: 2025-08-04 AccNo: 0001193125-25-172192 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 9.01: Financial Statements and Exhibits
New Form 8-K - 908 Devices Inc. Filed: 2025-08-04 AccNo: 0001104659-25-073391 Size: 223 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
NEOG Investors Have Opportunity to Lead Neogen Corporation Securities Fraud Lawsuit
Aptorum Group Limited Regains Compliance with NASDAQ’s Minimum Bid Price Requirement
INmune Bio’s CaRe PC Trial of INKmune™ in Metastatic Castration-Resistant Prostate Cancer Meets
Guardant Health, Inc. - American Cancer Society and Guardant Health Partner to Expand Cancer Screening Access and Advance Health Equity